Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

PASG Q4 2018 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$28M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$6M

Net Income

-$6M

EPS (Diluted)

$-4.80

Cash Flow

Operating Cash Flow

-$18,567

Free Cash Flow

-$18,595

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$33M

Total Liabilities

$307,000

Stockholders' Equity

$31M

Cash & Equivalents

$25M

← FY 2018 All Quarters Q1 2019 →